Fukushima; Shigeto

Patent Applications and Registrations

Patent applications and USPTO patent grants for Fukushima; Shigeto.The latest application filed is for "polyion complex micelle that includes antisense oligonucleotide and block copolymer of peg block and cationic polymer, said block copolymer having number-average molecular weight of 3-10 kda".

Company Profile

3.10.13

Fukushima; Shigeto - Kawasaki JP
FUKUSHIMA; Shigeto - Kanagawa JP
Fukushima; Shigeto - Tokyo JP
FUKUSHIMA; Shigeto - Kawasaki-shi JP
Fukushima; Shigeto - Narashino JP
Fukushima; Shigeto - Narashino-shi JP
Fukushima; Shigeto - Chiba-Ken JP

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Nucleic acid-loaded unit polyion complex Grant 11,324,835 - Kataoka , et al. May 10, 2	2022-05-10
POLYION COMPLEX MICELLE THAT INCLUDES ANTISENSE OLIGONUCLEOTIDE AND BLOCK COPOLYMER OF PEG BLOCK AND CATIONIC POLYMER, SAID BLOCK COPOLYMER HAVING NUMBER-AVERAGE MOLECULAR WEIGHT OF 3-10 kDa App 20210346290 - ANRAKU; Yasutaka ; et al.	2021-11-11
Unit structure-type pharmaceutical composition for nucleic acid delivery Grant 11,020,418 - Kataoka , et al. June 1, 2	2021-06-01
Nucleic Acid-loaded Unit Polyion Complex App 20200197527 - KATAOKA; Kazunori ; et al.	2020-06-25
Micelle containing epirubicin-complexed block copolymer and anti-cancer agent, and pharmaceutical composition containing said micelle applicable to treatment of cancer, resistant cancer or metastatic cancer Grant 10,220,026 - Kinoh , et al.	2019-03-05
Unit Structure-type Pharmaceutical Composition For Nucleic Acid Delivery App 20180153920 - KATAOKA; Kazunori ; et al.	2018-06-07
Unit Structure-type Pharmaceutical Composition For Nucleic Acid Delivery App 20180042955 - KATAOKA; Kazunori ; et al.	2018-02-15
Unit structure-type pharmaceutical composition for nucleic acid delivery Grant 9,808,480 - Kataoka , et al. November 7, 2	2017-11-07
Micelle Containing Epirubicin-complexed Block Copolymer And Anti-cancer Agent, And Pharmaceutical Composition Containing Said Micelle Applicable To Treatment Of Cancer, Resistant Cancer Or Metastatic Cancer App 20170258922 - Kinoh; Hiroaki ; et al.	2017-09-14
Particle composition and pharmaceutical composition using particle composition Grant 9,278,075 - Kataoka , et al. March 8, 2	2016-03-08
Unit Structure-type Pharmaceutical Composition For Nucleic Acid Delivery App 20150080454 - Kataoka; Kazunori ; et al.	2015-03-19
Particle Composition And Pharmaceutical Composition Using Particle Composition App 20140017328 - Kataoka; Kazunori ; et al.	2014-01-16
Polyethylene glycol/polycation block copolymers Grant 8,318,205 - Kataoka , et al. November 27, 2	2012-11-27
Electrostatically bonded polymer vesicle Grant 8,304,497 - Kataoka , et al. November 6, 2	2012-11-06
Polycationically charged polymer and the use of the same as a carrier for nucleic acid Grant 7,829,657 - Kataoka , et al. November 9, 2	2010-11-09
Polyethylene glycol/polycation block copolymers Grant 7,780,957 - Kataoka , et al. August 24, 2	2010-08-24
Polyethylene glycol/polycation block copolymers App 20100137512 - Kataoka; Kazunori ; et al.	2010-06-03
Electrostatically bonded polymer vesicle App 20090081458 - Kataoka; Kazunori ; et al.	2009-03-26
Polycationically Charged Polymer and the Use of the Same as a Carrier for Nucleic Acid App 20080249049 - Kataoka; Kazunori ; et al.	2008-10-09
Polyethylene glycol/polycation block copolymers App 20070059271 - Kataoka; Kazunori ; et al.	2007-03-15
Block copolymer reduced in impurity content, polymeric carrier, pharmaceutical preparations in polymeric form and process for the preparation of the same App 20040151690 - Nakanishi, Takeshi ; et al.	2004-08-05

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.